A Pharmacokinetic Study of Dexmedetomine in Infants
Status:
Completed
Trial end date:
2006-11-01
Target enrollment:
Participant gender:
Summary
Blind randomized trial of a single bolus dose of dexmedetomine followed by a continuous
infusion (CIVI) for up to 24 hours in infants who immediately post-operative from cardiac
surgery and require tracheal intubation with mechanical ventilation in the post-operative
period. Three bolus and infusion dose will be administered to a total of 36 patients.
Phase:
Phase 1
Details
Lead Sponsor:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)